Results 151 to 160 of about 182,063 (264)

Transcatheter Aortic Valve Replacement in Patients With Interstitial Lung Disease: A Cautionary Tale. [PDF]

JACC Case Rep
Schenkel R, Polycarpou A, Perlman D, Shumway S.   +3 more
europepmc   +1 more source

Expanding Remote Patient Monitoring for Pre-Lung Transplant Candidates With Interstitial Lung Disease. [PDF]

Clin Transplant
Wickerson L, De Mori T, Chowdhury N, Chaparro C, Marks N, Keshavjee S, Sidhu A.   +6 more
europepmc   +1 more source

Initial Treatment Strategies and Outcomes Across Hemodynamic Thresholds and Risk Stratification in Incident Systemic Sclerosis–Associated Pulmonary Arterial Hypertension: A EUSTAR Analysis

Arthritis &Rheumatology, EarlyView.
Objective Real‐world initial treatment strategies in systemic sclerosis–associated pulmonary arterial hypertension (SSc‐PAH) remain incompletely described. We aimed to characterize these strategies across hemodynamic thresholds and risk strata and evaluate outcome associations. Methods We analyzed treatment‐naive patients with SSc‐PAH from the European
Hilde Jenssen Bjørkekjær, Cosimo Bruni, Kaspar Broch, Cathrine Brunborg, Patricia E. Carreira, Paolo Airò, Carmen Pilar Simeón‐Aznar, Marie‐Elise Truchetet, Alessandro Giollo, Alexandra Balbir‐Gurman, Mickael Martin, Christopher P. Denton, Armando Gabrielli, Francesco Del Galdo, Madelon C. Vonk, Håvard Fretheim, Helle Bitter, Øyvind Midtvedt, Arne K. Andreassen, Sverre Høie, Yoshiya Tanaka, Gabriela Riemekasten, Ulf Müller‐Ladner, Marco Matucci‐Cerinic, Ivan Castellví, Elise Siegert, Eric Hachulla, Øyvind Molberg, Oliver Distler, Anna‐Maria Hoffmann‐Vold, on behalf of the European Scleroderma Trials and Research (EUSTAR) collaborators, Serena Guiducci, Florenzo Iannone, Simona Rednic, Yannick Allanore, Carlomaurizio Montecucco, Gábor Kumánovics, Michele Iudici, Gianluca Moroncini, Kristofer Andréasson, Luca Idolazzi, Jörg Henes, Johannes Pflugfelder, José António Pereira da Silva, Michael Hughes, Valeria Riccieri, Andra Balanescu, Ana Maria Gheorghiu, Christina Bergmann, Francesco Paolo Cantatore, Ellen De Langhe, Branimir Ani, Carolina de Souza Müller, Kamal Solanki, Edoardo Rosato, Britta Maurer, Lesley Ann Saketkoo, Massimiliano Limonta, Vivien M. Hsu, Lorinda S Chung, Yair Levy, Petros Sfikakis, Susana Oliveira, Masataka Kuwana   +63 more
wiley   +1 more source

Distinct BAL cytokine signatures define immunopathological endotypes in interstitial lung disease. [PDF]

Front Physiol
Osuna-Gómez R, Pardessus A, Mulet M, Hernández Marcos M, Ortiz MÀ, Pajares V, Cantó E, Francesqui J, Brenes JM, Guinart-Cuadra A, Vidal S, Castillo D.   +11 more
europepmc   +1 more source

Sema4A neutralization reduces fibrosis and inflammation in a mouse model of systemic sclerosis and a 3D model of immunity‐driven fibrosis

Arthritis &Rheumatology, Accepted Article.
Objective We previously showed that Semaphorin4A (Sema4A) is elevated in patients with systemic sclerosis (SSc) and promotes inflammation and fibrosis in vitro. Here, we examined the effect of Sema4A neutralization in vivo and in 3D fibrosis models. Methods Sema4A plasma levels were measured by ELISA in healthy controls (n=31) and patients with SSc (n=
Jaime Marty, Sara Martinez‐Ramos, Carlos Rafael‐Vidal, Beatriz Malvar‐Fernández, Tiago Carvalheiro, Ralph G. Tieland, Ines Ramos, Wiola Marut, Ana Pinheiro‐Lopes, Ana Argibay, Brenda Maure, Caritina Vázquez‐Triñanes, Nair Pérez Gómez, David Fernández‐Fernández, Sandra Vila, Coral Mouriño, Rogier M Thurlings, Arjan van Caam, Alberto Rivera, José María Pego‐Reigosa, Timothy R. Radstake, Samuel Garcia   +21 more
wiley   +1 more source

Thoracic ultrasound finding interstitial lung disease in SLE: a diagnostic test accuracy study. [PDF]

Rheumatol Adv Pract
Langkilde HZ, Sofíudóttir BK, Davidsen JR, Harders SMW, Luef SM, Kay SD, Svenungsson E, Fløjborg S, Christensen R, Voss A.   +9 more
europepmc   +1 more source

Oxygen therapy in interstitial lung disease - navigating benefit and burden. [PDF]

Curr Opin Pulm Med
Guler SA, Khor YH, Holland AE, Ekström M.   +3 more
europepmc   +1 more source

Safety of proton pump inhibitors in children: A systematic review

British Journal of Clinical Pharmacology, EarlyView.
Aim To systematically evaluate the safety of proton pump inhibitor (PPI) therapy in children aged 0–12 years, with a focus on treatment‐emergent adverse events across different study designs and age groups. Method The systematic review was carried out according to the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA ...
Ahmad Raza Sachel, Michael Rieder, Geert W. 't Jong   +2 more
wiley   +1 more source

Real-World Treatment Patterns in Rheumatoid Arthritis-Associated Interstitial Lung Disease. [PDF]

ACR Open Rheumatol
Dunn JT, Matson SM, George MD, Yang Y, Roul P, Kwizerimana JD, Rojas J, Cannon GW, Sauer B, Curtis JR, Baker JF, Mikuls TR, England BR.   +12 more
europepmc   +1 more source

Beyond wound sealing: A dual‐functional adhesive nanofiber membrane promoting coagulation and osteogenesis in extraction sites

BMEMat, EarlyView.
Inspired by the suction mechanics of octopus suckers, a dual‐layer nanofiber membrane integrates antibacterial protection, strong wet adhesion, and osteogenic support, offering a bioinspired strategy for effective hemostasis and alveolar bone preservation.
Huijing Ma, Liheng Gao, Hao Liang, Wentao Jiang, Junyi Wang, Jiajia Wang, Shuhan Duan, Lingxi Meng, Adilijiang Yimiti, Wenjie Zhang   +9 more
wiley   +1 more source